Interestingly, Tregs’ beneficial effects required intact CD39 (Ectonucleoside triphosphate diphosphohydrolase-1) signaling, suggesting that controlling purinergic metabolism may be an important Treg function in cardiovascular diseases (32). The gene discussed is ENTPD1; the disease is cardiovascular disorder.